pyridinolcarbamate has been researched along with Neurodermatitis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Neurodermatitis: An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grebennikov, VA | 1 |
1 other study available for pyridinolcarbamate and Neurodermatitis
| Article | Year |
|---|---|
[Basis for prescribing bradykinin antagonists in neurodermatitis and data on the therapeutic effectiveness of parmidin in this dermatosis].
Topics: Bradykinin; Carbamates; Drug Evaluation; Humans; Kinins; Neurodermatitis; Pyridinolcarbamate | 1982 |